BDNF and Cognitive impairment: Dansheninone IIA (TSA) ameliorates Pb-induced cognitive impairment by elevating SOD and GSH levels, decreasing malondialdehyde (MDA) concentration, and synergistically enhancing brain-derived neurotrophic factor (BDNF) expression (157).